Intuitive Surgical, Inc. (ISRG)
371.88
+2.63
(+0.71%)
USD |
NASDAQ |
Sep 02, 16:00
372.03
+0.15
(+0.04%)
After-Hours: 05:01
Intuitive Surgical Research and Development Expense (TTM) : 1.414B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.414B |
| March 31, 2026 | 1.357B |
| December 31, 2025 | 1.312B |
| September 30, 2025 | 1.254B |
| June 30, 2025 | 1.210B |
| March 31, 2025 | 1.177B |
| December 31, 2024 | 1.145B |
| September 30, 2024 | 1.111B |
| June 30, 2024 | 1.074B |
| March 31, 2024 | 1.038B |
| December 31, 2023 | 997.40M |
| September 30, 2023 | 980.70M |
| June 30, 2023 | 947.80M |
| March 31, 2023 | 910.70M |
| December 31, 2022 | 876.30M |
| September 30, 2022 | 810.50M |
| June 30, 2022 | 758.90M |
| March 31, 2022 | 710.60M |
| December 31, 2021 | 659.90M |
| September 30, 2021 | 631.30M |
| June 30, 2021 | 611.40M |
| March 31, 2021 | 593.20M |
| December 31, 2020 | 579.30M |
| September 30, 2020 | 583.70M |
| June 30, 2020 | 571.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 549.70M |
| December 31, 2019 | 546.70M |
| September 30, 2019 | 512.10M |
| June 30, 2019 | 484.60M |
| March 31, 2019 | 460.10M |
| December 31, 2018 | 411.80M |
| September 30, 2018 | 378.60M |
| June 30, 2018 | 354.50M |
| March 31, 2018 | 343.80M |
| December 31, 2017 | 321.40M |
| September 30, 2017 | 302.40M |
| June 30, 2017 | 281.00M |
| March 31, 2017 | 250.40M |
| December 31, 2016 | 229.20M |
| September 30, 2016 | 212.30M |
| June 30, 2016 | 200.20M |
| March 31, 2016 | 194.50M |
| December 31, 2015 | 185.70M |
| September 30, 2015 | 180.80M |
| June 30, 2015 | 177.40M |
| March 31, 2015 | 168.20M |
| December 31, 2014 | 166.50M |
| September 30, 2014 | 160.70M |
| June 30, 2014 | 156.70M |
| March 31, 2014 | 158.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Stryker Corp. | 1.606B |
| Zimmer Biomet Holdings, Inc. | 442.90M |
| Abbott Laboratories | 3.128B |
| Boston Scientific Corp. | 2.153B |
| Globus Medical, Inc. | 147.06M |